These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. The splenectomy effects on blood coagulation. I. Enzymatic process alterations in coagulation. Carriazo D; Nieto M; Galarza A Rev Esp Fisiol; 1974 Dec; 30(4):217-22. PubMed ID: 4456475 [No Abstract] [Full Text] [Related]
47. [Anomalies of hemostasis in hepatopathies]. Oliver JM; Gruel Y; Bacq Y Gastroenterol Clin Biol; 1991; 15(10):679-88. PubMed ID: 1816008 [No Abstract] [Full Text] [Related]
48. [Necessary diagnosis of hemostasis for surgical practice]. Lasch HG; Krause W Chirurg; 1967 Dec; 38(12):541-5. PubMed ID: 5626747 [No Abstract] [Full Text] [Related]
49. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period). Koert M; Nowak-Göttl U; Kreuz W; Grüttner HP; Kornhuber B; Breddin HK Klin Padiatr; 1991; 203(6):429-32. PubMed ID: 1721940 [TBL] [Abstract][Full Text] [Related]
50. [Introduction to congenital abnormalities of plasma proteins involved in blood clotting, fibrinolysis and their regulations]. Saito H Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):955-8. PubMed ID: 3078054 [No Abstract] [Full Text] [Related]
51. Synthetic oligopeptide substrates: their diagnostic application in blood coagulation, fibrinolysis, and other pathologic states. Huseby RM; Smith RE Semin Thromb Hemost; 1980; 6(3):175-314. PubMed ID: 7006083 [No Abstract] [Full Text] [Related]
52. [Study of some blood coagulation factors and fibrinolysis in patients with artificial heart valves]. Ciko Z; Sokolić J; Papo I; Martinović N Vojnosanit Pregl; 1975; 32(5):484-9. PubMed ID: 1210068 [No Abstract] [Full Text] [Related]
53. Coagulation profile in diabetes and its association with diabetic microvascular complications. Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694 [TBL] [Abstract][Full Text] [Related]
54. [Increased predisposition to thrombogenesis in patients with diabetes mellitus]. Feĭgin MB Vrach Delo; 1966 Oct; 10():54-6. PubMed ID: 5996363 [No Abstract] [Full Text] [Related]
56. [Interaction of tissue and blood factors in consumption coagulopathies and fibrinolysis]. Nijs M; Brassinne C; Coune A; Tagnon HJ Bull Acad R Med Belg; 1967; 7(7):643-60. PubMed ID: 5621729 [No Abstract] [Full Text] [Related]
57. [Therapy of plasma coagulation defects. II. Acquired coagulation disorders]. Schmutzler R Dtsch Med Wochenschr; 1966 Feb; 91(7):316-8. PubMed ID: 5295337 [No Abstract] [Full Text] [Related]
58. [Clinical significance of disorders in the blood coagulation system in children with diabetes mellitus (literature survey)]. Viadro SS; Martynova MI Vopr Okhr Materin Det; 1976 Apr; 21(4):61-5. PubMed ID: 997345 [No Abstract] [Full Text] [Related]
59. [Studies on coagulation and fibrinolysis. IV. Observation on coagulability and fibrinolytic activity in diabetics]. Hu YM; Xue H; Wang KQ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):388-9. PubMed ID: 6233025 [No Abstract] [Full Text] [Related]
60. [Coagulation, fibrinolysis and various diseases: diabetes mellitas]. Abe T Nihon Rinsho; 1974 May; 32(5):1072-4. PubMed ID: 4858914 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]